WHO European health information at your fingertips.

Indicator is part of data set(s):

HFA-DB

Indicator full name: Disability-adjusted life expectancy, by sex

Unit: years

Dimensions:

Country/Area (COUNTRY/AREA)
Supranational group of countries (COUNTRY_GRP)
Sex (SEX)
Year of measure (YEAR)

Years data is available: 2000—2015

Last updated: 21 October 2025

(Sub)regional averages available for:

Members of the EU before Feb 2020
Western Balkans

Export to:

HFA-DB

European Health for All database

Indicators: 618

Updated: 21 October 2025

Contact: Data, Artificial Intelligence and Digital Health unit (DAD)

The following abbreviations are used in the indicator titles:

• SDR: age-standardized death rates (see HFA-DB user manual/Technical notes, page 13, for details)

• FTE: full-time equivalent

• PP: physical persons

• PPP$: purchasing power parities expressed in US $, an internationally comparable scale reflecting the relative domestic purchasing powers of currencies.

Indicator notes

WHO Global Health Estimates provide a comprehensive and comparable set of DALY estimates from year 2000 onwards. The sum of these DALYs across the population, or the burden of disease, can be thought of as a measurement of the gap between current health status and an ideal health situation where the entire population lives to an advanced age, free of disease and disability.

DALYs for a disease or health condition are calculated as the sum of the Years of Life Lost (YLL) due to premature mortality in the population and the Years Lost due to Disability (YLD) for people living with the health condition or its consequences.

Because these estimates draw on new data and on the results of the GBD 2015 study, and there have been substantial revisions to methods for many causes, these estimates for the years 2000-2015 are not directly comparable with previous WHO estimates of DALYs.

For more detailed information on the methods used to calculate disability-adjusted life expectancy, see http://www.who.int/healthinfo/global_burden_disease/GlobalDALYmethods_2000_2015.pdf?ua=1

Country/Area notes

No information

General notes

Understanding Disability-Adjusted Life Expectancy (DALE)

Disability-Adjusted Life Expectancy, or DALE, is a health metric used by researchers and policymakers to assess the overall burden of disease within a population. It extends beyond traditional life expectancy by accounting for the impact of disabilities and chronic health conditions on the quality of life. DALE provides a more nuanced view of health outcomes by combining years lived with disability and years of life lost due to premature mortality. This metric helps in understanding not just how long people live, but how well they live, offering a clearer picture of a population's health status.

The Significance of Disability-Adjusted Life Expectancy

DALE is crucial for effective health policy-making and resource allocation. By highlighting the diseases and conditions that cause significant disability, it helps health authorities prioritize interventions that can improve quality of life, not just extend it. For instance, if a population has a high DALE loss due to mental health disorders, targeted mental health services can be strengthened. Moreover, DALE encourages a shift from merely treating diseases to promoting overall well-being and preventing diseases that cause long-term disability, aligning health systems more closely with the needs of the population.

Strengths and Limitations of Disability-Adjusted Life Expectancy

While DALE is a valuable tool for health assessment, it comes with its own set of strengths and limitations.

Strengths

DALE's major strength lies in its comprehensive approach to measuring health outcomes. By accounting for both mortality and morbidity, it provides a more complete picture of a population's health than traditional life expectancy. This dual focus helps policymakers understand the full impact of health conditions on societal well-being and economy. Additionally, DALE can be instrumental in tracking progress over time or comparing health status across different regions or countries, facilitating global health initiatives and cooperation.

Limitations

However, the accuracy of DALE is heavily dependent on the quality and availability of data on mortality and morbidity. In regions where health reporting is inconsistent or incomplete, DALE estimates may be less reliable. The metric also assumes a uniform impact of disabilities across different cultures and personal circumstances, which may not accurately reflect the true burden of disability in diverse populations. Furthermore, DALE does not account for the short-term fluctuations in health status that can occur due to outbreaks or seasonal variations, potentially overlooking acute health crises.

In conclusion, while Disability-Adjusted Life Expectancy is a powerful tool for understanding and improving population health, it must be used judiciously, considering its methodological constraints and the quality of underlying data. As health data systems continue to improve globally, the reliability and utility of DALE as a health metric are expected to enhance, supporting more informed and effective health policy decisions.